In a panel of mouse leukemic cells engineered to be dependent on exogenously expressed human antiapoptotic BCL-2 family members45, ABBV-467 showed selective inhibition of the human MCL-1–expressing B-cell acute lymphoblastic leukemia variant (Supplementary Table S3). Here, MCL1 is linked to B-cell acute lymphoblastic leukemia.